Devonian Health Group Inc. (TSXV:GSD)
7.74
+0.24 (3.20%)
Oct 30, 2026, 9:30 AM EDT
Devonian Health Group Employees
As of July 31, 2025, Devonian Health Group had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year. That makes Devonian Health Group the 40,156th largest employer in the world and 769th in Canada.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
299.53K CAD
Profits / Employee
-611.28K CAD
Market Cap
21.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2025 | 11 | 3 | 37.50% | 8 | 3 |
| Jul 31, 2024 | 8 | 1 | 14.29% | 6 | 2 |
| Jul 31, 2023 | 7 | - | - | 6 | 1 |
| Jan 31, 2017 | 5 | - | - | 5 | 0 |
| Oct 31, 2016 | 5 | - | - | 5 | 0 |
Devonian Health Group News
- 11 days ago - Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine™ Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients - PRNewsWire
- 15 days ago - Devonian Health Group Provides Update on its Planned NYSE American Listing - PRNewsWire
- 7 weeks ago - Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American - PRNewsWire
- 2 months ago - Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay - PRNewsWire
- 2 months ago - Devonian Health Group Anticipates to Commence Trading on the NYSE American - PRNewsWire
- 3 months ago - Devonian Health Group Slides: Investor presentation - Filings
- 3 months ago - Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering - PRNewsWire
- 3 months ago - Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years - PRNewsWire